γδ T cells show distinct responses to CMV after stem cell transplantation
Journal of Molecular Medicine · 2026-12 · 104 (1)
DOI: 10.1007/s00109-026-02703-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Medicine, online erschienen am 20.07.2026. Verfasst von Freya Sibbertsen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Systems Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Receptors, Antigen, T-Cell, gamma-delta, Cytomegalovirus, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf (UKE).
Abstract (Originalsprache)
Cytomegalovirus (CMV) reactivation is a frequent complication after allogeneic hematopoietic stem cell transplantation (aHSCT) and critically shapes immune reconstitution. However, the clonal and functional dynamics of T cell responses to CMV remain insufficiently defined. In this study, we combined longitudinal single-cell RNA sequencing with paired T cell receptor sequencing to track γδ and αβ T cell clones at clonal resolution across five post-transplant time points in patients with and without CMV reactivation. This integrative approach revealed marked, patient-specific expansion of non-Vγ9Vδ2 γδ T cell clones, particularly within Vδ1⁺ and Vδ3⁺ subsets, which was associated with differentiation toward cytotoxic and antiviral effector states characterized by IFN-γ and TNF-α expression. Conventional CD8⁺ αβ T cells showed comparatively modest clonal dynamics during CMV reactivation in this cohort. Longitudinal tracking of individual clonotypes demonstrated heterogeneous but recurrent trajectories, with expanding γδ T cell clones frequently acquiring antiviral and cytotoxic phenotypes following CMV reactivation. These findings highlight the adaptive-like behavior and functional plasticity of non-Vγ9Vδ2 γδ T cells and provide a high-resolution framework for studying antiviral immune responses during immune reconstitution. Key messages Single-cell sequencing enables clonal tracking of T cells during CMV reactivation. γδ T cells show patient-specific clonal expansion after CMV reactivation. Expanding γδ T cell clones acquire antiviral and cytotoxic phenotypes. Vγ9Vδ2 γδ T cells remain stable with limited clonal expansion. αβ T cells display limited clonal responses during CMV reactivation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Systems Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Medical Systems Bioinformatics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Immunology, Hannover Medical School, Hannover, Germany.
- Deutsches Zentrum für Kinder- und Jugendgesundheit (DZKJ), Hamburg, Germany.
Förderung
- Universitätsklinikum Hamburg-Eppendorf (UKE)
Zitieren
APA
Sibbertsen, F., Song, Z., Ly, C., Sandrock, I., Bonn, S., Koenecke, C., Tan, L., Schultze-Florey, C., & Prinz, I. (2026). γδ T cells show distinct responses to CMV after stem cell transplantation. Journal of Molecular Medicine, 104(1). https://doi.org/10.1007/s00109-026-02703-8
Vancouver
Sibbertsen F, Song Z, Ly C, Sandrock I, Bonn S, Koenecke C, et al. γδ T cells show distinct responses to CMV after stem cell transplantation. Journal of Molecular Medicine. 2026;104(1). doi:10.1007/s00109-026-02703-8
BibTeX
@article{Sibbertsen2026,
author = {Sibbertsen, Freya and Song, Zheng and Ly, Cedric and Sandrock, Inga and Bonn, Stefan and Koenecke, Christian and Tan, Likai and Schultze-Florey, Christian and Prinz, Immo},
title = {γδ T cells show distinct responses to CMV after stem cell transplantation},
journal = {Journal of Molecular Medicine},
year = {2026},
volume = {104},
number = {1},
doi = {10.1007/s00109-026-02703-8}
}
EUVIMED